Biomarker: F246-IgE Guar Bean Gum

Overview

F246-IgE measures serum immunoglobulin E antibodies specific to guar bean gum, a plant-derived thickener and stabilizer also called guar gum. IgE participates in immediate hypersensitivity reactions by binding allergens and activating mast cells, which can release histamine and other inflammatory mediators. An elevated result indicates sensitization to guar gum and may support evaluation of suspected food-related, occupational respiratory, or contact reactions, while a low or undetectable result makes sensitization less likely but does not completely exclude clinical allergy. Specific IgE testing is clinically useful when interpreted with exposure history and symptoms, but a positive result alone does not establish allergy or predict reaction severity.

Clinical Use Cases

Support evaluation of suspected IgE-mediated reactions after eating foods or taking products containing guar gum.
Investigate occupational rhinitis or asthma associated with inhalation of guar gum powder. Human studies have reported immediate skin reactivity and serum IgE antibodies in exposed workers.
Support evaluation of rare suspected guar-gum-associated anaphylaxis when the clinical history is consistent.
Identify sensitization to guar gum as part of a focused allergy assessment.
Complement, but not replace, clinical history, physical examination, skin-prick testing, and medically supervised oral or inhalation challenge when appropriate.

Specimen Types

Venous serum, typically collected from whole blood.
Skin-prick-test extract or preparation may be used for complementary testing, but it is not the specimen used for serum F246-IgE measurement.

Measurement Methods

In-vitro allergen-specific IgE immunoassay using a guar-gum allergen extract.
Fluorescence-labeled antibody assays, including ImmunoCAP-type platforms, for detecting circulating allergen-specific IgE.
Enzyme-linked immunosorbent assay, or ELISA, has been used in human research to detect IgE antibodies to gum extracts.
Skin-prick testing may be used as a complementary method, although it measures immediate skin reactivity rather than serum F246-IgE.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergy blood test.
Patients should report antihistamines, corticosteroids, biologic medications, and other treatments to the ordering clinician. Medication effects depend on the testing method, and antihistamines are more likely to affect skin testing than serum testing.
Results should be interpreted in relation to the timing and route of guar-gum exposure, symptoms, and alternative explanations.
Inhalational exposure may be particularly relevant in occupational rhinitis or asthma investigations.
A positive result indicates sensitization, not necessarily clinical allergy. The concentration does not reliably predict reaction severity.
Results may vary with the allergen extract, assay platform, reporting units, and laboratory reference ranges.
Cross-reactive antibodies to other plant-derived gums may complicate interpretation, particularly when several gum extracts test positive.
A negative result does not absolutely exclude allergy because extract composition, processing-related allergen changes, timing, and assay sensitivity can affect detection.
Oral or inhalation challenge should only be considered under appropriate specialist supervision because it can provoke a reaction.